Hydrochloric Acid → 2-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)-8-((cis)-3-fluoropiperidin-4-yloxy)quinoline dihydrochloride
Reaction equation
[N:1]1[N:2]=[C:3]([C:10]2[CH:19]=[CH:18][C:17]3[C:12](=[C:13]([O:20][C@H:21]4[CH2:26][CH2:25][NH:24][CH2:23][C@H:22]4[F:27])[CH:14]=[CH:15][CH:16]=3)[N:11]=2)[N:4]2[CH:9]=[CH:8][CH:7]=[CH:6][C:5]=12.[ClH:28].O1CCOCC1>CO>[ClH:28].[ClH:28].[N:1]1[N:2]=[C:3]([C:10]2[CH:19]=[CH:18][C:17]3[C:12](=[C:13]([O:20][C@H:21]4[CH2:26][CH2:25][NH:24][CH2:23][C@H:22]4[F:27])[CH:14]=[CH:15][CH:16]=3)[N:11]=2)[N:4]2[CH:9]=[CH:8][CH:7]=[CH:6][C:5]=12Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
Non-racemic 2-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-8-((cis)-3-fluoropiperidin-4-yloxy)quinoline (20 mg, 0.055 mmol) was dissolved in MeOH (2 mL) and treated with 4M HCl in dioxane (1 mL, 4 mmol). The mixture was stirred for 5 minutes then concentrated in vacuo. The residue was dissolved in fresh MeOH and concentrated in vacuo three times to a pale yellow solid (20.7 mg, 86%). Specific rotation: [α]20D=+26° (c=0.45, 1:1 water/95% ethanol).
Workup
- concentrationthen concentrated in vacuo
- dissolutionThe residue was dissolved in fresh MeOH
- concentrationconcentrated in vacuo three times to a pale yellow solid (20.7 mg, 86%)
Sources & evidence
- ORD record
- ord-30951e6add064d31a791c81134cd7c10
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08987251B2
Reaction notes
Loading…